Leading Digital Dentistry Company Fussen Technology Secures Series D Strategic Investment from Beijing Taikang Investment
VCBeat has learned that Shenzhen Feisen Technology Co., Ltd. (“Feisen Technology”), a leading provider of comprehensive digital dentistry solutions in China, recently announced the completion of its Series D strategic financing round. This round was exclusively invested by the Zhangjiagang Taikang Qianzhen Equity Investment Fund, under Beijing Taikang Investment Management Co., Ltd. (“Beijing Taikang Investment”). The proceeds will be primarily used to continuously optimize the company’s digital imaging hardware products and accelerate the upgrade of its software platform. China Renaissance served as the exclusive financial advisor to Feisen Technology in this transaction.
Shenzhen Feisen Technology Co., Ltd., founded in 2010 and headquartered in Shenzhen, is a leading provider of comprehensive digital dentistry solutions in China. Leveraging digital hardware and software—including digital dental imaging equipment and SaaS systems—as its entry point, the company has built a digital dentistry platform that connects upstream and downstream industry resources. It offers value-added services based on high-value dental data and a 3D dental design platform, ultimately achieving full coverage of end-user dental product solutions.
Yang Weizhen, CEO of Feisen Technology, stated: “With this strategic investment by Beijing Taikang Investment in Feisen Technology, and in the spirit of win-win cooperation to foster the development of a digital dental ecosystem, Feisen Technology will leverage its digital new infrastructure and solutions to enable the broader and more extensive application of the significant value that digitization brings to oral healthcare services.”
Chen Yilun, General Manager of the Investment Management Department of Taikang Insurance Group and Chairman of Beijing Taikang Investment, stated: “For many years, Taikang has remained committed to implementing the Healthy China strategy, with oral health serving as a key strategic pillar within Taikang’s comprehensive healthcare ecosystem. This investment and the establishment of a strategic business partnership represent another significant move by Taikang Insurance Group to deepen its presence across the dental industry chain. We will promote synergy and mutual empowerment among our core insurance business, healthcare ecosystem initiatives, and investment operations. We are confident that, through the joint efforts of all parties involved, we will not only achieve win-win cooperation but also create an innovative business model for the development of the oral healthcare sector and the commercial dental insurance industry.”
Huang Shengxuan, CEO of Beijing Taikang Investment, stated: “We are delighted to be the sole investor in this round of financing for Feisen Technology and to promote deep collaboration between Taikang’s insurance and dental healthcare businesses and Feisen. As a private equity investment platform under Taikang Asset Management, we are committed to leveraging our insurance resource advantages to create investment value. As a leading enterprise in the digital dentistry sector, we believe that this investment and strategic business partnership will usher in a new phase of development for Feisen Technology and also contribute to the growth of Taikang’s broader health ecosystem.”
As the investment banking advisor for this transaction, Li Gang, Partner at China Renaissance, stated: “China’s oral healthcare market exceeds RMB 100 billion in size, with numerous players spanning devices, consumables, supply chains, and service providers. However, what we value about Feisen Technology is its rare capability in China to build new digital infrastructure for dentistry and its commitment to transforming the entire industry ecosystem through digital means. Within just a few years, the company has achieved synergistic development of digital hardware and SaaS software, and has successfully expanded into consumer-facing digital terminal solutions. China Renaissance is honored to have assisted Feisen Technology in completing this round of strategic financing and introducing Taikang Insurance, a strategic investor with deep expertise in the oral care sector. We are highly confident that both parties will achieve win-win cooperation and jointly establish a leading global company in the digital dentistry industry.”
Beijing Taikang Investment Management Co., Ltd. is one of the first batches of insurance private equity fund managers approved by the former China Insurance Regulatory Commission (CIRC), and serves as a specialized private equity fund management platform under Taikang Asset Management. Adhering to Taikang Asset’s investment culture driven by research and excellence, Beijing Taikang Investment aims to build a leading, professional, and market-oriented private equity institution. Leveraging an investment strategy driven by three pillars—direct investment funds, funds of funds (FOFs), and insurance ecosystem resources—the company focuses on investing in outstanding enterprises and top-tier vertical sector funds in the fields of big health, innovative technology, and major consumer sectors.
China Renaissance is a leading new-economy investment bank in China, focusing on three major sectors globally: TMT, consumer, and healthcare. In addition to its investment banking services, China Renaissance manages one RMB-denominated fund and one USD-denominated fund. The firm maintains offices in Beijing, Shanghai, Los Angeles, and San Francisco, and holds licenses to operate in the U.S. securities markets. Healthcare is a key focus area where China Renaissance boasts deep expertise; it has ranked for four consecutive years as the new-economy investment bank with the highest number of healthcare industry transactions in China. Furthermore, China Renaissance possesses the largest, most professional, and most comprehensively integrated healthcare investment banking team in the country.